Showing results (1-10 of 126) with videos related to
Sort By:
Pageof 13
Statistics in Medicine|April 6, 2006
A method for therapeutic dose selection in a phase II clinical trial using contrast statisticsAkira Wakana, Isao Yoshimura, Chikuma HamadaJournal of Biopharmaceutical Statistics|January 19, 2012
Sample size calculation through the incorporation of heteroscedasticity and dependence for a penalized t-statistic in microarray experimentsAkihiro Hirakawa, Chikuma Hamada, Isao YoshimuraMethods of Information in Medicine|March 14, 2009
A note on estimating treatment effect for time-to-event data in a literature-based meta-analysisTadashi Hirooka, Chikuma Hamada, Isao YoshimuraBioinformatics and Biology Insights|October 9, 2009
A new test statistic based on shrunken sample variance for identifying differentially expressed genes in small microarray experimentsAkihiro Hirakawa, Yasunori Sato, Chikuma Hamada, et al.Statistics in Medicine|September 7, 2005
Effective number of subjects and number of raters for inter-rater reliability studiesYuki Saito, Takashi Sozu, Chikuma Hamada, et al.Contemporary Clinical Trials|June 30, 2006
Minimization method for balancing continuous prognostic variables between treatment and control groups using Kullback-Leibler divergenceAkira Endo, Fumio Nagatani, Chikuma Hamada, et al.Journal of Biopharmaceutical Statistics|February 26, 2010
Optimal two-stage designs allowing flexibility in number of subjects for phase II clinical trialsNobuyuki Masaki, Tatsuki Koyama, Isao Yoshimura, et al.Cancer Informatics|May 21, 2009
Estimating the false discovery rate using mixed normal distribution for identifying differentially expressed genes in microarray data analysisAkihiro Hirakawa, Yasunori Sato, Takashi Sozu, et al.Journal of Human Genetics|January 7, 2005
Designing a multistage, SNP-based, genome screen for common diseasesYasunori Sato, Hideki Suganami, Chikuma Hamada, et al.Drug Safety|August 19, 2007
Criteria revision and performance comparison of three methods of signal detection applied to the spontaneous reporting database of a pharmaceutical manufacturerYasuyuki Matsushita, Yasufumi Kuroda, Shinpei Niwa, et al.Pageof 13